login
login

Europe Daily Bulletin No. 13023

17 September 2022
Contents Publication in full By article 15 / 29
EU RESPONSE TO COVID-19 / Health
EMA recommends continued authorisation of Moderna and BioNTech-Pfizer’s ‘Covid’ vaccines
Brussels, 16/09/2022 (Agence Europe)

The European Medicines Agency (EMA) announced on Friday 16 September, following the meeting of its Committee for Medicinal Products for Human Use (CHMP) (12-15 September), that it recommended converting the conditional marketing authorisations granted to the Covid-19 messenger RNA vaccines Comirnaty, developed by Pfizer andBioNTech, and Spikevax, developed by Moderna, into a standard marketing authorisation. This decision is taken during the second annual renewal procedure of this...

Contents

FUNDAMENTAL RIGHTS - SOCIETAL ISSUES
SECTORAL POLICIES
INSTITUTIONAL
EXTERNAL ACTION
EU RESPONSE TO COVID-19
EUROPEAN PARLIAMENT PLENARY
COUNCIL OF EUROPE
NEWS BRIEFS
ADDENDUM